BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31176573)

  • 41. Classical cadherin and catenin expression in normal myometrial tissues and uterine leiomyomas.
    Tai CT; Lin WC; Chang WC; Chiu TH; Chen GT
    Mol Reprod Dev; 2003 Feb; 64(2):172-8. PubMed ID: 12506349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
    Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B
    Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
    Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
    J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.
    Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI
    Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
    Mangrulkar RS; Ono M; Ishikawa M; Takashima S; Klagsbrun M; Nowak RA
    Biol Reprod; 1995 Sep; 53(3):636-46. PubMed ID: 7578688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas.
    Barker KT; Spendlove HE; Banu NS; Bridge JA; Fisher C; Shipley J; Garrett M; Manyonda I; Houlston RS
    Cancer Lett; 2006 Apr; 235(1):136-40. PubMed ID: 15949892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mast cells in smooth muscle tumors of the uterus.
    Orii A; Mori A; Zhai YL; Toki T; Nikaido T; Fujii S
    Int J Gynecol Pathol; 1998 Oct; 17(4):336-42. PubMed ID: 9785134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
    Strissel PL; Swiatek J; Oppelt P; Renner SP; Beckmann MW; Strick R
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):42-7. PubMed ID: 17646097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
    Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
    Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice.
    Moore AB; He H; Yoshida A; Rico PJ; Haseman JK; Dixon D
    Exp Toxicol Pathol; 2000 Jun; 52(3):195-200. PubMed ID: 10930119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
    Sahly NN; Banaganapalli B; Sahly AN; Aligiraigri AH; Nasser KK; Shinawi T; Mohammed A; Alamri AS; Bondagji N; Elango R; Shaik NA
    Syst Biol Reprod Med; 2021 Jun; 67(3):209-220. PubMed ID: 33685300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
    Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
    Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
    Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
    Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of allelic loss as an adjuvant tool in evaluation of malignancy in uterine smooth muscle tumors.
    Esposito NN; Hunt JL; Bakker A; Jones MW
    Am J Surg Pathol; 2006 Jan; 30(1):97-103. PubMed ID: 16330948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of matricellular proteins in human uterine leiomyomas and normal myometrium.
    Bogusiewicz M; Semczuk A; Juszczak M; Langner E; Walczak K; Rzeski W; Tomaszewski J; Rechberger T
    Histol Histopathol; 2012 Nov; 27(11):1495-502. PubMed ID: 23018248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PEP-19 overexpression in human uterine leiomyoma.
    Kanamori T; Takakura K; Mandai M; Kariya M; Fukuhara K; Kusakari T; Momma C; Shime H; Yagi H; Konishi M; Suzuki A; Matsumura N; Nanbu K; Fujita J; Fujii S
    Mol Hum Reprod; 2003 Nov; 9(11):709-17. PubMed ID: 14561813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors?
    Garcia N; Bozzini N; Baiocchi G; da Cunha IW; Maciel GA; Soares Junior JM; Soares FA; Baracat EC; Carvalho KC
    Hum Pathol; 2016 Apr; 50():43-50. PubMed ID: 26997437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus.
    Wang L; Felix JC; Lee JL; Tan PY; Tourgeman DE; O'Meara AT; Amezcua CA
    Gynecol Oncol; 2003 Aug; 90(2):402-6. PubMed ID: 12893208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas.
    Guo J; Zheng J; Tong J
    Int J Med Sci; 2024; 21(7):1227-1240. PubMed ID: 38818470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
    Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
    Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.